Skip to main content

And ... Recruited

Randy Schekman will be the first editor of the new open-access journal being formed by the Howard Hughes Medical Institute, the Max Planck Society, and the Wellcome Trust, according to a news release from HHMI. Schekman is a cell biologist and the current editor-in-chief of the Proceedings of the National Academy of Sciences. According to HHMI, he will begin working on the new journal in August, dedicating half of his time to that project while also helping PNAS find his successor. For the new journal, Schekman says he expects it to use Creative Commons licenses and that, for the first few years, no fees will be charged to authors. "It is my strong feeling that there is a need for a scientific journal at the very high end that is run by active practicing scientists embedded in an academic environment, individuals who experience both the frustrations and satisfactions of research," he says in a statement. "The scientific journals that are now at the high end are doing some things right, but I think there is room at the top for an alternative approach."

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.